Tags: Drug.

Farampator (CX-691 Org 24448) is an ampakine drug. It was developed by Cortex Pharmaceuticals and licensed to Organon BioSciences for commercial development. Following the purchase of Organon by Schering-Plough in 2007 the development license to farampator has been transferred and development is continuing.Farampator has been investigated for its effect on AMPA receptors and researched for potential use in the treatment of schizophrenia and Alzheimer’s Disease.

Farampator.svg
ATC prefix
none
CAS number
211735-76-1
FDA UNII code
7X6P5N8K2L
IUPAC name
213-benzoxadiazol-6-yl-piperidin-1-ylmethanone
PubChem
4118151

Loading...

This page contains content from the copyrighted Wikipedia article "Farampator"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.